![Tom Gibbs](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Tom Gibbs
Directeur/Membre du Conseil chez
BC Platforms AG
Profil
Dr. Tom Gibbs is a Senior Investment Director at Debiopharm Investment SA. He is on the Board of Directors at BC Platforms AG and Carevive Systems, Inc.
He received his doctorate degree from the University of Warwick.
Postes actifs de Tom Gibbs
| Sociétés | Poste | Début |
|---|---|---|
BC Platforms AG
 BC Platforms AG Data Processing ServicesTechnology Services Provides healthcare data management and analytics services | Directeur/Membre du Conseil | 01/06/2017 |
Carevive Systems, Inc.
 Carevive Systems, Inc. Packaged SoftwareTechnology Services Develops integrated cancer care management software | Directeur/Membre du Conseil | - |
Debiopharm Investment SA
 Debiopharm Investment SA Investment ManagersFinance Debiopharm Investment invests in small and mid-market companies located in Europe. The firm focuses on next gen pharma R&D, clinical trial tech and digital medicine sectors. It provides financing in the form of debt and equity for pre-seed, seed and early stage transactions with an investment size of USD 1 - 5 million. The firm makes co-investments and takes minority interests. It also acts as a lead investor. | Private Equity Investor | - |
Formation de Tom Gibbs
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
21
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
University of Warwick
 University of Warwick Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Debiopharm Investment SA
Debiopharm Investment SA Investment ManagersFinance Debiopharm Investment invests in small and mid-market companies located in Europe. The firm focuses on next gen pharma R&D, clinical trial tech and digital medicine sectors. It provides financing in the form of debt and equity for pre-seed, seed and early stage transactions with an investment size of USD 1 - 5 million. The firm makes co-investments and takes minority interests. It also acts as a lead investor. | Finance |
Carevive Systems, Inc.
Carevive Systems, Inc. Packaged SoftwareTechnology Services Develops integrated cancer care management software | Technology Services |
BC Platforms AG
BC Platforms AG Data Processing ServicesTechnology Services Provides healthcare data management and analytics services | Technology Services |
